SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-200281
Filing Date
2018-06-22
Accepted
2018-06-22 08:57:09
Documents
3
Period of Report
2018-06-22
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d583749d8k.htm 8-K 27879
2 EX-3.1 d583749dex31.htm EX-3.1 7564
3 EX-3.2 d583749dex32.htm EX-3.2 101583
  Complete submission text file 0001193125-18-200281.txt   138628
Mailing Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-779-5075
ARMO BioSciences, Inc. (Filer) CIK: 0001693664 (see all company filings)

IRS No.: 273454138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38345 | Film No.: 18913185
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1